Literature DB >> 567939

The emergence of candidosis. The dominant postmortem cerebral mycosis.

J C Parker, J J McCloskey, R S Lee.   

Abstract

Comparable human postmortem surveys in central Kentucky and southern Florida have demonstrated an altered pattern of cerebral mycoses due primarily to therapeutic manipulations. From both states 8,975 complete autopsies yielded 39 patients with histologically verified cerebral mycoses. The most common infection was candidosis (49%), characterized by intraparenchymal microabscesses without significant leptomeningitis in hospitalized patients compromised by antibiotic therapy for infection with gram-negative organisms. The remaining 20 patients with noncandidal cerebral mycoses included 9 (23%) with cryptococcosis, 5 (13%) with zygomycosis, 2 (5%) with aspergillosis, 2 (5%) with histoplasmosis, 1 (2.5%) with blastomycosis and 1 (2.5%) with curvulariosis. These compromised patients had leptomeningitis when infected with yeasts and cerebral infarcts with cerebritis when infected with hyphal fungi. In contrast to human cerebral candidosis, the non-candidal cerebral mycoses precipitated the patient's terminal hospitalization. These infections seemed to be contracted outside the hospital. Therapy for gram-negative bacterial infections has enabled Candida species to overtake Cryptococcus neoformans as the most common cause of postmortem cerebral mycosis.

Entities:  

Mesh:

Year:  1978        PMID: 567939     DOI: 10.1093/ajcp/70.1.31

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Spinal cord swelling and candidiasis. A case report.

Authors:  K Ho; A Williams; G Gronseth; M Aldrich
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

2.  Intracranial mycotic infections in neurosurgical practice.

Authors:  A B Jamjoom; S A al-Hedaithy; Z A Jamjoom; M al-Hedaithy; S F el-Watidy; N Rahman; M al-Moallem
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Cerebral infection complicating systemic aspergillosis in acute leukemia: clinical and radiographic presentation.

Authors:  J A Sparano; R Gucalp; J F Llena; F G Moser; P H Wiernik
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

4.  Adhesion of Candida albicans to brain tissue of Macaca mulata in an ex vivo assay.

Authors:  F J Denaro; J L López-Ribot; W L Chaffin
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Therapy of fungal infections of the central nervous system.

Authors:  D C Speller
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

6.  Cerebral candidiasis. Computed tomography appearance.

Authors:  M Chaabane; H Krifa; M F Ladeb; M H Bouhaouala; M Ben Hammouda; R Ataalah; A Gannouni
Journal:  Pediatr Radiol       Date:  1989

7.  Mycopathology of cerebral mycosis.

Authors:  R Malik; V Malhotra; R Gondal; P C Bechar; T K Malik; S Kumar
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

8.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.

Authors:  M N Guentzel; C Herrera
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

9.  Intracranial Aspergillus granuloma.

Authors:  C Sundaram; J M K Murthy
Journal:  Patholog Res Int       Date:  2011-12-10

Review 10.  Innate Immune and Fungal Model of Alzheimer's Disease.

Authors:  Bodo Parady
Journal:  J Alzheimers Dis Rep       Date:  2018-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.